EBERS’ CEO, Pedro Moreo, participated in the symposium on “Cutting-edge Regenerative Medicine” organized by Clínica Universidad de Navarra and CIMA research institute. He gave his view on the current situation of organ transplantation and presented the latest results obtained in the NORMOPERF (normoperf.eu) project financed by the European Commission.
EBERS’ research collaborator, Dr. Álex Gutiérrez, presented the last results obtained with the ARK normothermic perfusion system for ex vivo kidney preservation at the annual meeting of the Spanish Society for Transplantation (SET 2021). The scientific meeting was expected to take place in Málaga, Spain on February 12 – 14, but due to the restrictions imposed by the COVID-19 pandemic it was celebrated virtually. Dr. Gutiérrez gave an oral presentation titled “Ex vivo normothermic perfusion reduces cold ischemic damage and delayed graft function in an experimental model of renal transplantation”, where he discussed the benefits obtained in post-transplant renal function derived from the use of EBERS’ ARK KIDNEY device during the preservation of the graft.